Therapeutic and preventing effect of probiotics for antibiotic-associated diarrhea in elderly severe lung infection
10.3969/j.issn.1005-1678.2017.02.086
- VernacularTitle:益生菌制剂在老年重症肺部感染中对抗生素相关性腹泻的临床疗效
- Author:
Xiaoxia LOU
;
Lili SHEN
;
Jieyun HU
;
Shangzhi XU
;
Kai TANG
- Keywords:
probiotics agents;
flora imbalance;
elderly;
severe pulmonary infection;
antibiotic-associated diarrhea
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(2):276-278
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe clinical efficacy of probiotics agents in the prevention and treatment of severe pulmonary infection in elderly patients with antibiotic-associated diarrhea (AAD).Methods 60 cases of elderly patients with severe pulmonary infection (more than or equal to 60 years old) were randomly divided into the treatment group ( 31 cases ) and control group ( 29 cases ) , the control group received broad-spectrum antibiotics or using two linked above anti-infection treatment, the treatment group were added with probiotic agent ( lactobacillus complex capsules).The diarrhea, the use of antibiotics and the stool routine, bacteria before and after 5, 10, 15 days of group were observed.Results After 15 days treatment, the number of Escherichia coli in treatment group was lower than that in control group (P<0.05), the number of Bacterium lacticum and Bifidobacterium bifidum in treatment group were higher than those in control group ( P<0.05 ) .The AAD rate in treatment goup was 12.90%, which was lower than 41.38% in control group (P<0.05).There were significant differences in beginning time and duration of diarrhea between two groups (P<0.05). Conclusion The intestinal probiotics reduced induced by antibiotics in elderly patients with severe pulmonary infection , the probiotics agents could redress intestinal flora imbalance, keep the steady state of intestinal flora, and prevent and cure the antibiotic-associated diarrhea.
